Solvias, an independent pharmaceutical testing and manufacturing company, has acquired Netherlands-based Cergentis to bolster its biologics and cell & gene therapy testing capabilities. Cergentis marks Solvias’ second acquisition since partnering with health care investors Water
Tags :Solvias AG
Bär & Karrer advises shareholders of Solvias in connection with investment by Water Street